Author: Zhang, Qingyu; Liu, Lihua; Sun, Wei; Gao, Fuqiang; Cheng, Liming; Li, Zirong
Title: Extracorporeal shockwave therapy in osteonecrosis of femoral head: A systematic review of now available clinical evidences Document date: 2017_1_27
ID: 4t5bjbtu_24
Snippet: In 2008, Wang et al [17] published a article included 14 patients involving 14 diseased hips graded as ARCO stage III or IV, all of which underwent THA. 7 cases also received ESWT before surgery and others were regarded as control group. ESWT group revealed more live bone and less necrotic bone as well as higher cell concentration and activity compared with control group. Factors for angiogenesis such as von Willebrand factor (vWF), CD31, vascula.....
Document: In 2008, Wang et al [17] published a article included 14 patients involving 14 diseased hips graded as ARCO stage III or IV, all of which underwent THA. 7 cases also received ESWT before surgery and others were regarded as control group. ESWT group revealed more live bone and less necrotic bone as well as higher cell concentration and activity compared with control group. Factors for angiogenesis such as von Willebrand factor (vWF), CD31, vascular cell adhesion molecule (VCAM) as well as for bone remodeling and regeneration such as Winless 3a (Wnt 3), Dickkopf-1 (DKK1) and proliferation cell nuclear antigen (PCNA) also had significant differences between ESWT group and control group. These findings prompted the regeneration effects of ESWT to ONFH.
Search related documents:
Co phrase search for related documents- eswt regeneration effect and regeneration effect: 1
- high cell concentration and proliferation cell: 1, 2
- necrotic bone and proliferation cell: 1
- significant difference and surgery control group regard: 1
- significant difference and vascular vcam cell adhesion molecule: 1, 2
- significant difference and vcam cell adhesion molecule: 1, 2
- significant difference and von Willebrand factor: 1, 2, 3, 4, 5
- significant difference and vWF von Willebrand factor: 1, 2, 3, 4, 5
- significant difference and Willebrand factor: 1, 2, 3, 4, 5
- vascular vcam cell adhesion molecule and vcam cell adhesion molecule: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
- vascular vcam cell adhesion molecule and von Willebrand factor: 1, 2
- vascular vcam cell adhesion molecule and vWF von Willebrand factor: 1, 2
- vascular vcam cell adhesion molecule and Willebrand factor: 1, 2
- vcam cell adhesion molecule and von Willebrand factor: 1, 2
- vcam cell adhesion molecule and vWF von Willebrand factor: 1, 2
- vcam cell adhesion molecule and Willebrand factor: 1, 2
- von Willebrand factor and vWF von Willebrand factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- von Willebrand factor and Willebrand factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- vWF von Willebrand factor and Willebrand factor: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
Co phrase search for related documents, hyperlinks ordered by date